search
Back to results

Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Primary Purpose

Lumbar Herniated Disc

Status
Terminated
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Percutaneous Hydrodiscectomy
TESI
Sponsored by
Montefiore Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lumbar Herniated Disc

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Single level subligamentous lumbar disc herniation with a size of up to 1/3 of the spinal canal sagittal diameter, with unilateral radicular pain attributed to nerve root impingement from lumbar disc material correlated with MRI or CT findings
  • Axial MRI demonstrating unilateral focal contained disc herniation with single nerve contact
  • Patient failed at least 3 weeks of conservative management within a 6 month period including anti-inflammatory medication and physical therapy
  • Patient has not had previous epidural steroid injections at the affected lumbar level within 3 months of presenting for the study
  • Patient is a candidate for transforaminal epidural steroid injections
  • Positive Straight Leg Raising (SLR) test
  • Patient has a leg pain > back pain
  • The subject is physically and mentally able to participate in the study
  • Patient is willing and able to provide informed consent
  • Patient is willing and able to comply with the study protocol

Exclusion Criteria:

  • Patient has had surgery at the affected level
  • Extruded or sequestered disc herniation
  • Free fragment herniation
  • Discogenic pain without nerve root compression
  • Previous surgery at the involved lumbar level
  • Segmental instability (motion on flexion/extension films)
  • Spondylolisthesis > Grade 2
  • Severe central canal stenosis or bony impingement at the index level
  • Significant loss of disc height (> 60%) compared with the adjacent higher level or disc height < 6mm at affected level
  • Motor deficit (strength rating less than 4/5 in the lower extremity test)
  • Positive Waddell test (> 3 of 5 tests)
  • Active local or systemic infection
  • Actively in litigation for pain symptoms
  • Currently on Workman's Compensation
  • Women who are pregnant

Sites / Locations

  • Montefiore Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Percutaneous Hydrodiscectomy

TESI

Arm Description

Percutaneous Hydrodiscectomy with the SpineJet Hydrodiscectomy System

Transforaminal Epidural Steroid Injections

Outcomes

Primary Outcome Measures

Number of Patients in Each Group That Experience at Least a 50% Reduction in Leg and Back Pain
Pain improvement in all patients in HydroD arm with at least 50% reduction in leg and back pain.

Secondary Outcome Measures

Change From Baseline Oswestry Disability Index (ODI)
Change From Baseline ED-5Q Questionnaire

Full Information

First Posted
April 8, 2015
Last Updated
February 13, 2020
Sponsor
Montefiore Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02414698
Brief Title
Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy
Official Title
Single Center, Randomized PROspective Study Comparing Percutaneous HydroDiscectomy to Transforaminal Epidural Steroid Injections in the Treatment Of Radiculopathy Secondary to Lumbar Disc Herniation (PROPHESOR)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Terminated
Why Stopped
Integral investigator left study; could not continue recruiting.
Study Start Date
January 2015 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
March 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Montefiore Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To compare the outcomes of percutaneous lumbar Hydrodiscectomy (HydroD) with the SpineJet Hydrodiscectomy System to transforaminal epidural steroid injections (TESI) in patients with lumbar radiculopathy due to contained disc herniation with symptoms that persist following a treatment course of conservative management including physical therapy and anti-inflammatory medication.
Detailed Description
Lumbar disc herniation is one of the leading causes of lower back pain and sciatica. If conservative management fails to relieve radiculopathy secondary to lumbar disc herniation, interventional treatments such as epidural steroid injections are indicated. Patients that do not have pain relief from transforaminal epidural steroid injections or over time relief is diminished, surgical intervention is typically recommended and microdiscectomy is the surgical intervention of choice. Over the years, a number of minimally invasive techniques for lumbar disc herniation have been introduced including percutaneous mechanical lumbar discectomy, including percutaneous hydrodiscectomy (HydroD). The purpose of this study is to compare the outcomes of HydroD with the SpineJet Hydrodiscectomy System to transforaminal epidural steroid injections (TESI) in patients with lumbar radiculopathy due to contained disc herniation that have failed a course of conservative management including anti-inflammatory medication and physical therapy. Patients will be randomized in a 1:1 ratio to Percutaneous Hydrodiscectomy or Transforaminal Epidural Steroid Injections. Patients randomized to the TESI group that fail to have >50% relief of pain after two courses of TESI injections spaced two weeks apart within 2 months of the procedure, will be provided with the option to cross-over to the HydroD group after which they will follow the same follow-up visits. If after cross-over into the HydroD group they fail to have >50% relief of pain after the initial intervention within 2 months of the procedure, they will be referred for surgery and their participation in the study will end. Patients randomized to the HydroD group that fail to have >50% relief of pain after the initial procedure, or within 2 months of the procedure, will be provided with the option to cross-over to the TESI group. If after cross-over to the TESI group they fail to have >50% relief of pain after two courses of TESI injections spaced two weeks apart within 2 months of the procedure, they will be referred for surgery and will no longer be followed in the study. Patients will be followed at 1, and 4, and 2, 6, 12, and 24 months post-procedure. Outcomes assessments include NRS for pain, ODI, neurological and independent physician evaluations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Herniated Disc

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Percutaneous Hydrodiscectomy
Arm Type
Active Comparator
Arm Description
Percutaneous Hydrodiscectomy with the SpineJet Hydrodiscectomy System
Arm Title
TESI
Arm Type
Active Comparator
Arm Description
Transforaminal Epidural Steroid Injections
Intervention Type
Procedure
Intervention Name(s)
Percutaneous Hydrodiscectomy
Intervention Description
The HydroD uses a thin supersonic stream of water to cut, ablation, remove disc material percutaneously via a skin puncture.
Intervention Type
Drug
Intervention Name(s)
TESI
Other Intervention Name(s)
Transforaminal epidural steroid injections
Intervention Description
Transforaminal epidural steroid injections given in the lumbar spine.
Primary Outcome Measure Information:
Title
Number of Patients in Each Group That Experience at Least a 50% Reduction in Leg and Back Pain
Description
Pain improvement in all patients in HydroD arm with at least 50% reduction in leg and back pain.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change From Baseline Oswestry Disability Index (ODI)
Time Frame
24 months
Title
Change From Baseline ED-5Q Questionnaire
Time Frame
24 months
Other Pre-specified Outcome Measures:
Title
Global Improvement Impression of Change (PGIC)
Description
Patient self assessment of the Global Improvement Impression of Change (PGIC)
Time Frame
24 months
Title
Independent Physician Assessment (McNab Criteria)
Time Frame
24 months
Title
Adverse Events
Description
Procedure and device related adverse events
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Single level subligamentous lumbar disc herniation with a size of up to 1/3 of the spinal canal sagittal diameter, with unilateral radicular pain attributed to nerve root impingement from lumbar disc material correlated with MRI or CT findings Axial MRI demonstrating unilateral focal contained disc herniation with single nerve contact Patient failed at least 3 weeks of conservative management within a 6 month period including anti-inflammatory medication and physical therapy Patient has not had previous epidural steroid injections at the affected lumbar level within 3 months of presenting for the study Patient is a candidate for transforaminal epidural steroid injections Positive Straight Leg Raising (SLR) test Patient has a leg pain > back pain The subject is physically and mentally able to participate in the study Patient is willing and able to provide informed consent Patient is willing and able to comply with the study protocol Exclusion Criteria: Patient has had surgery at the affected level Extruded or sequestered disc herniation Free fragment herniation Discogenic pain without nerve root compression Previous surgery at the involved lumbar level Segmental instability (motion on flexion/extension films) Spondylolisthesis > Grade 2 Severe central canal stenosis or bony impingement at the index level Significant loss of disc height (> 60%) compared with the adjacent higher level or disc height < 6mm at affected level Motor deficit (strength rating less than 4/5 in the lower extremity test) Positive Waddell test (> 3 of 5 tests) Active local or systemic infection Actively in litigation for pain symptoms Currently on Workman's Compensation Women who are pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sayed E Wahezi, MD
Organizational Affiliation
Montefiore Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montefiore Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

We'll reach out to this number within 24 hrs